HARRIS ROBERT LEWIS 4

4 · AMARANTUS BIOSCIENCE, INC. · Filed Jan 16, 2013

Form 4

Period: 2010-12-13

Director

Transactions

Purchase
Common Stock
2013-01-14$0.10/sh+50,000$4,900→ 1,394.332 total
Award
5% Convertible Preferred Stock
2012-07-15+31,250→ 6,961,541 total
Exercise: $1.50→ Common Stock (1,562,500 underlying)
Award
Convertible Series B Preferred Stock
2012-07-15$0.00/sh+31,250$31→ 31,250 total
Award
Convertible Note
2010-12-13$50000.00/sh+1$50,000→ 2,761,986 total
Exercise: $0.04→ Common Stock (2,761,986 underlying)
Award
5% Convertible Preferred Stock
2012-11-04+100,000→ 11,961,541 total
Exercise: $1.50→ Common Stock (5,000,000 underlying)
Award
Convertible Note
2010-04-27$100000.00/sh+1$100,000→ 4,119,863 total
Exercise: $0.04→ Common Stock (1,357,877 underlying)
Award
Convertible Note
2011-08-27$50000.00/sh+1$50,000→ 5,399,041 total
Exercise: $0.04→ Common Stock (1,279,178 underlying)
Purchase
Common Stock
2012-07-26$0.01/sh+7,000$105→ 1,344,332 total
Award
Convertible Series B Preferred Stock
2012-11-04$0.00/sh+100,000$100→ 131,250 total

Footnotes (3)

[F1]No specific date set.
[F2]Set based upon current price, actual price will be determine on the date of conversion.
[F3]N/A

Documents

1 file